Bard Announces 5 Million Share Purchase Authorization.

Business Editors

MURRAY HILL, N.J.--(BUSINESS WIRE)--Dec. 12, 2002

The Board of Directors of C. R. Bard C. R. Bard, Inc. (NYSE: BCR) is one of the large S&P 500 companies of the United States, a surgical specialties and hospital medical device manufacturer in Murray Hill, New Jersey. It is named after its founder, who sold the company within only a few years of its founding. , Inc. (NYSE NYSE

See: New York Stock Exchange :BCR BCR B Cell Receptor
BCR Business Communications Review (magazine)
BCR Banca Comerciala Romana (Romanian bank)
BCR Breakpoint Cluster Region
BCR Benefit/Cost Ratio
BCR Bay City Rollers ) at its December 11th meeting approved the purchase of up to 5 million shares of its common stock.

This new authorization follows the nearly completed buyback of the 10 million shares authorized by the Board in July 1998. The new shares along with the remaining 512,500 shares from the 1998 authorization will be acquired from time to time, consistent with past practice.

C. R. Bard, Inc., (www.crbard.com) headquartered in Murray Hill, New Jersey

For other places with the same name, see Murray Hill.

Murray Hill is an unincorporated area within portions of both Berkeley Heights and New Providence, located in Union County in north-central New Jersey. , is a leading multinational developer, manufacturer and marketer of health care products in the fields of vascular, urology, oncology and surgical specialty products.

COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Publication:	Business Wire
Date:	Dec 12, 2002
Words:	121
Previous Article:	Extendicare Inc. Declares Dividends on its Preferred Shares; TSX: EXE.PR.B, EXE.PR.C, EXE.PR.D and EXE.PR.E.
Next Article:	National Council of La Raza Partners with General Mills to Promote Libromania and Goes Book Crazy!

Related Articles
MEDCHEM PRODUCTS, INC. TO MERGE INTO C. R. BARD, INC.
Collagen Corp. reports first quarter, including previously reported in-process R&D charge; Trilucent breast implant launched in Germany, Switzerland...
Collagen Corp. Reports Second Fiscal Quarter Results; Collagen emphasizes programs for continued investment in "appearance" medicine arena.
Bard directors extend share purchase program.
Bard Directors Extend Share Purchase Program.
Bard Directors Authorize 10 Million Share Purchase Program.
VENTURA COUNTY APPROVES FUNDS FOR HEALTH BUILDING.
Bard Announces $500 Million Share Repurchase Authorization.